Medicare and Medicaid
HIMSS25
With healthcare spending, particularly for Medicare Advantage, under scrutiny, 1upHealth's Dr. Don Rucker says AI-ready, open API platforms that can integrate and analyze disparate data are needed to inform care and control costs.
Millie founder and CEO Anu Sharma discusses reasons why one-third of the U.S. is considered a "maternity care desert" and what can be done.
The organization is seeking feedback on how to best advance digital health to empower seniors using technology, while reducing administrative burdens and improving interoperability.
Cindy Henry, director of population health informatics at ZeOmega, explores the recent trends in Star Ratings, the contributing factors behind lower scores across the board and strategies to adapt as the program's standards continue to rise.
Attorney Everett Wilson, managing partner at Polsinelli's Miami office, discusses overall changes in Medicare and Medicare Advantage - and how the recent benefits changes affect consumers, payers and plans.
Donald Rucker, chief strategy officer at 1upHealth, discusses the details associated with CMS' Medicare Star Ratings, balancing the complexity and interest of patients and taxpayers, and what plans need to do to up their rating.
Jenn Kerfoot, chief strategy and growth officer at DUOS, discusses why only seven plans made five stars for Medicare Advantage Star Ratings, as opposed to 30 the previous year, and how plans can ensure a positive rating in the future.
Healthcare attorney and partner at Holland & Knight Zubin Khambatta discusses the CMS final rule related to Medicaid managed care and its provisions adding new compliance guardrails regarding state-directed payments.
Ann Maxwell, deputy inspector general for evaluations at the U.S. Department of Health and Human Services Office of Inspector General, discusses the case for making the pandemic-related CMS telehealth expansion permanent.
Jennifer Mathieu, senior vice president of professional and government affairs at AMCP, provides an update on the Access to Prescription Digital Therapeutics Act 2023 moving through Congress.